Scientists from the University of Pittsburgh School of Medicine have developed a potential vaccine against SARS-CoV-2, the novel coronavirus causing the COVID-19 pandemic. The researchers were able to succeed as they had thoroughly researched the virus during the previous coronavirus outbreaks. Researchers tested this vaccine in mice by injecting through a fingertip-sized patch and were able to generate a wave of antibodies against SARS-CoV-2 within two weeks of the microneedle prick. Scientists are now waiting for approval from the U.S. Food and Drug Administration so they can start a phase I human clinical trial as soon as possible.